drugset / Trial / NCT03603132

A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

NCT03603132

Phase 1 Completed 15 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupOpen-labelOther

Summary

This study use a single-center, randomized, open, three-cycle, self-control trial design. It is planning to enroll 15 healthy adult male subjects. Fifteen subjects will randomize into 3 test groups which corresponding to 3 different dosing sequences. Subjects will be giving a single oral dose in per cycle, and there will have three types of breakfast administration after each treatment. Washing period is 10 days during the cycle.

Timeline

Start
2018-07-14
Primary completion
2018-08-17
Completion
2018-08-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hetrombopag Olamine Unknown 7.5 mg Oral